Please login to the form below

celecoxib

This page shows the latest celecoxib news and features for those working in and with pharma, biotech and healthcare.

Products over pipeline in Pfizer's acquisition targets, hints CEO

Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex (celecoxib) last December in the US, with competition already being felt

Latest news

Pfizer 2014 guidance threatened by Celebrex competition

courts. Several generic pharma companies have been planning to launch copycat versions of Celebrex (celecoxib) in the US on May 30, when the basic patent on the active ingredient of the
Pfizer sales down but oncology shows promise

There were also gains for anti-inflammatory Celebrex (celecoxib), up 11 per cent to $752m, while fibromyalgia drug Lyrica (pregabalin) cemented its position as Pfizer's biggest-selling product with a
Pfizer sales dip as net income surges in Q2

Epilepsy, neuropathic pain and fibromyalgia therapy Lyrica (pregabalin) cemented its position as Pfizer's biggest product with a 10 per cent gain to $1.13bn, while painkiller Celebrex (celecoxib) grew 10
GSK fires senior Chinese scientist over data fabrication

to faking dozens of research studies, including trials of Pfizer's Celebrex (celecoxib) and Merck &Co's Vioxx (rofecoxib).
Pfizer sues as Celebrex patent is reissued in US

Celebrex (celecoxib) remains a major product for Pfizer, with global sales growing 9 per cent to $2.7bn last year, mainly as a treatment for osteoarthritis. ... We are pleased with the reissuance of this patent protecting the invention of using celecoxib

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest appointments

Immunocore names CEO

During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Digital Health Specialist – Global Agency: Salary TBC

Home-based Senior Medical Writer – Med Ed: Salary TBC

Health Consultant - Brand Comms: Competitive Salary

Home based, Senior Medical Writer, Medical Communications: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Scientific Director – Medical Communications: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Senior Account Director – Healthcare Advertising – London: Salary TBC

Programme/ Account Director - Healthcare PR - London: Salary TBC

EU Head of Business Development and Client Service: Exceptional packge and bonus

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Medical Writer: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Associate Director – Social Healthcare – London: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Home-based Medical Writer – Medical Education: Salary TBC

Creative/ Medical Writer: Circa £35, 000 With Benefits

Managing Director – Global Medical Writing & Scientific Exce...: £120-150K

AM – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager, Medical Communications, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience: Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution: Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....